Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.
All Work
Lee Jackson
3 Top Retail Stocks to Buy That Pay Dividends of Almost 5% and More
With the gas prices expected to remain low at least through this year, and probably in to 2017, the consumers now may be looking to buy some of the things they want and need…
Analyst Raises Targets on Red-Hot Permian Basin Energy Stocks
These three outstanding companies continue to be favorites across Wall Street. All are participating in the basin many think is the best in the country, and all are extremely well run.
Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming
Investors are now focusing on fundamentals and near-term catalysts that could provide a tailwind for some of the biotech leaders.
4 Top Dividend Stocks That Should Do Great Regardless of Who Is President
While there is no guarantee that these stocks all thrive after the November election, they all have very strong and mature franchises that should continue to drive earnings regardless of who sits in the…
3 Oil Service Giants to Buy as Rig Count Slowly Improves
A new UBS research report makes the case that oil services earnings are starting to surprise to the upside somewhat.
Jefferies Top Growth Stocks to Buy Have Big Upside Potential
A new Jefferies research report has four new growth stocks to buy that could have some serious upside potential.
3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential
The analysts at Stifel have noted three biotech companies that not only have data that could prove to be huge, but also have stocks that have been absolutely hammered over the past year.
Jefferies Likes Growth Over Value Now: 4 Top Stocks to Buy
In a new research report from Jefferies, top-notch equity strategist Steven DeSanctis makes the case that now is the time to rotate to growth stocks from value, and he sees relative valuations still very…
4 Top Tech Stocks That Beat Earnings May Be Strong Buys Now
RBC makes the case that earnings so far this year are relatively stronger than some anticipated, and it notes that companies that did come in with positive earnings surprises were treated well by investors.
RBC Analysts Have Spotted 4 Top Momentum Stock Buys
With the dollar's strength abating and the economy growing, albeit slowly, the analysts at RBC are staying positive on the current market.
Jefferies Makes Another Big Summer Change to Its Franchise Picks List
In a recent research note, the analysts at Jefferies made a big move by adding Ball Corp. to the firm's well-respected Franchise Picks list of stocks to buy.
UBS Dividend Ruler Stocks Continue to Crush S&P 500: 4 Yield Leaders to Buy
The UBS Dividend Ruler portfolio continue to outperform the overall market, and we continue to think that the outperformance will stay in place for the rest of the year and beyond.
NYSE Blue Chips Targeted as Insider Buying Jumps: ConocoPhillips, Bank of America, Boeing, Caterpillar and More
With August comes the end of the bulk of second-quarter earnings, and it also opens windows for insiders to buy and sell stock again, and boy did we see a jump in volume last…
2 Gigantic Trades Highlight Insider Selling: GrubHub, Cooper-Standard, AON, Knight Transportation, Comcast and More
It should come as no surprise to see insider selling at current market levels, and we expect the pace to continue through the rest of the summer and into the fall.
Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick
A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in the top position.
Domestic Dividend Stocks the Only Place to Be: 4 to Buy With Big Revenues in the US
These are clearly not the most exciting companies on Wall Street, but if you are an investor concerned about where to own shares, the United States remains the clear-cut winner.
Merrill Lynch Says the Time to Put Money Into Biotech Is Now
Though these four large cap biotech stocks are cheap relative to the S&P 500, history says they won’t stay that way.
4 Top Merrill Lynch Buy-Rated Stocks That Yield 5% or More
With so much of the sovereign debt around the world with negative yields, and the rest just barely over the breakeven level, many people are looking far and wide for any sort of reasonable…
Jefferies Has 4 Top Financial Stocks to Buy Ahead of the Election
If the Jefferies strategist is right, and history repeats itself, these four top stock should all do outstanding over the next three months.